Tau Protein and Anti-Tau Antibodies in Patients with Multiple Sclerosis

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F12%3A11687" target="_blank" >RIV/00064165:_____/12:11687 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/12:43903694 RIV/00023752:_____/12:43913802 RIV/00216208:11110/12:11687 RIV/00216208:11120/12:43903694
Result on the web
<a href="http://www.csnn.eu/ceska-slovenska-neurologie-clanek/tau-protein-a-anti-tau-protilatky-u-pacientu-s-roztrousenou-sklerozou-38120" target="_blank" >http://www.csnn.eu/ceska-slovenska-neurologie-clanek/tau-protein-a-anti-tau-protilatky-u-pacientu-s-roztrousenou-sklerozou-38120</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Tau Protein and Anti-Tau Antibodies in Patients with Multiple Sclerosis
Original language description
No significant correlation between the tau protein concentrations and anti-tau antibody levels (serum, CSF or intrathecal) in the multiple sclerosis (MS) group or in the controls was found. Neither the CSF tau concentration or any calculated ratio between tau and anti-tau antibodies differed between MS patients and controls. The tau protein released into CSF and the anti-tau humoral response are independent processes in MS and are not distinct from other neurological patients.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—

Project
<a href="/en/project/NS10369" target="_blank" >NS10369: Use of neurocytoskeletal proteins and antibodies against them for diagnosis of Alzheimer´s disease</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)